BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 26729387)

  • 1. Diagnostic and prognostic accuracy of miR-21 in renal cell carcinoma: a systematic review protocol.
    Rasti A; Mehrazma M; Madjd Z; Keshtkar AA; Roudi R; Babashah S
    BMJ Open; 2016 Jan; 6(1):e009667. PubMed ID: 26729387
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of MicroRNAs associated with early relapse after nephrectomy in renal cell carcinoma patients.
    Slaby O; Redova M; Poprach A; Nekvindova J; Iliev R; Radova L; Lakomy R; Svoboda M; Vyzula R
    Genes Chromosomes Cancer; 2012 Jul; 51(7):707-16. PubMed ID: 22492545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship of miR-181a expression level and AML: A systematic review protocol.
    Koolivand M; Moein S; MalekZadeh K
    Int J Surg Protoc; 2019; 13():1-4. PubMed ID: 31851750
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of spinal orthoses and postural taping on balance, gait and quality of life in older people with thoracic hyperkyphosis: protocol for a systematic review and meta-analysis.
    Aboutorabi A; Arazpour M; Ahmadi Bani M; Keshtkar AA
    BMJ Open; 2018 Jan; 8(1):e015813. PubMed ID: 29391361
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long non-coding RNAs enable precise diagnosis and prediction of early relapse after nephrectomy in patients with renal cell carcinoma.
    Bohosova J; Kozelkova K; Al Tukmachi D; Trachtova K; Naar O; Ruckova M; Kolarikova E; Stanik M; Poprach A; Slaby O
    J Cancer Res Clin Oncol; 2023 Aug; 149(10):7587-7600. PubMed ID: 36988708
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of Gram-negative bacteria in ventilator-associated pneumonia in neonatal intensive care units: a systematic review and meta-analysis protocol.
    Erfani Y; Rasti A; Janani L
    BMJ Open; 2016 Oct; 6(10):e012298. PubMed ID: 27729350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Accuracy of c-KIT in Lung Cancer Prognosis; a Systematic Review Protocol" instead of c-KIT Expression in Lung Cancer Prognostic Evaluation - a Systematic Review Protocol.
    Roudi R; Kalantari E; Keshtkar A; Madjd Z
    Asian Pac J Cancer Prev; 2016; 17(2):863-6. PubMed ID: 26925693
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Do statins improve outcomes for patients with non-small cell lung cancer? A systematic review and meta-analysis protocol.
    Li F; Liu G; Roudi R; Huang Q; Swierzy M; Ismail M; Zhao S; Rueckert JC
    BMJ Open; 2018 Sep; 8(9):e022161. PubMed ID: 30206083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MicroRNA-15a tissue expression is a prognostic marker for survival in patients with clear cell renal cell carcinoma.
    Mytsyk Y; Borys Y; Tumanovska L; Stroy D; Kucher A; Gazdikova K; Rodrigo L; Kruzliak P; Prosecky R; Urdzik P; Dosenko V
    Clin Exp Med; 2019 Nov; 19(4):515-524. PubMed ID: 31440867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting disease progression after nephrectomy for localized renal cell carcinoma: the utility of prognostic models and molecular biomarkers.
    Crispen PL; Boorjian SA; Lohse CM; Leibovich BC; Kwon ED
    Cancer; 2008 Aug; 113(3):450-60. PubMed ID: 18523999
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Can microRNAs be utilized as tumor markers for recurrence following nephrectomy in renal cell carcinoma patients? A meta-analysis provides the answer.
    Aalami AH; Abdeahad H; Aalami F; Amirabadi A
    Urol Oncol; 2023 Jan; 41(1):52.e1-52.e10. PubMed ID: 36280530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic significance of miRNAs as potential biomarkers for human renal cell carcinoma: a systematic review and meta-analysis.
    Gu Y; Yuan J
    Expert Rev Anticancer Ther; 2022 Apr; 22(4):437-444. PubMed ID: 35255782
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of microRNAs in head and neck cancers: a systematic review and meta-analysis protocol.
    Kumarasamy C; Devi A; Jayaraj R
    Syst Rev; 2018 Oct; 7(1):150. PubMed ID: 30285880
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of miRNA-106b in conventional renal cell carcinoma is a potential marker for prediction of early metastasis after nephrectomy.
    Slaby O; Jancovicova J; Lakomy R; Svoboda M; Poprach A; Fabian P; Kren L; Michalek J; Vyzula R
    J Exp Clin Cancer Res; 2010 Jul; 29(1):90. PubMed ID: 20609231
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential prognostic value of miRNAs as biomarker for progression and recurrence after nephrectomy in renal cell carcinoma: a literature review.
    Fasanella D; Antonaci A; Esperto F; Scarpa RM; Ferro M; Schips L; Marchioni M
    Diagnosis (Berl); 2021 Oct; 9(2):157-165. PubMed ID: 34674417
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of HIV and HCV in people who inject drugs: a systematic and meta-analysis review protocol.
    Sharhani A; Jorjoran Shushtari Z; Rahmani A; Armoon B; Noroozi M; Ahounbar E; Karimi SE; Higgs P
    BMJ Open; 2021 Jan; 11(1):e041482. PubMed ID: 33452193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The miR-200 family as prognostic markers in clear cell renal cell carcinoma.
    Saleeb R; Kim SS; Ding Q; Scorilas A; Lin S; Khella HW; Boulos C; Ibrahim G; Yousef GM
    Urol Oncol; 2019 Dec; 37(12):955-963. PubMed ID: 31635993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic and clinicopathological value of PBRM1 expression in renal cell carcinoma.
    Wang Z; Peng S; Guo L; Xie H; Wang A; Shang Z; Niu Y
    Clin Chim Acta; 2018 Nov; 486():9-17. PubMed ID: 30006290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MicroRNA-15a expression measured in urine samples as a potential biomarker of renal cell carcinoma.
    Mytsyk Y; Dosenko V; Borys Y; Kucher A; Gazdikova K; Busselberg D; Caprnda M; Kruzliak P; Farooqi AA; Lubov M
    Int Urol Nephrol; 2018 May; 50(5):851-859. PubMed ID: 29549624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.